News & Updates

In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.

Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.

AONN+ Board Member Andrea (Andi) Dwyer helped lead a three-year collaboration with the CDC and policymakers that resulted in new ICD-10 codes for Lynch Syndrome, BRCA1, BRCA2, and Li-Fraumeni Syndrome, improving coverage and access to genetic testing and diagnostic services for patients.

AONN+ encourages oncology navigators to complete a brief Commission on Cancer survey that will help shape future navigation program development, identify emerging trends, and strengthen support for the oncology navigation community.

AONN+ Midyear 2026 brought the oncology navigation community together for four days of connection, innovation, and practical insights that are shaping the future of patient care.

Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, recently traveled to Philadelphia to represent AONN+ at the Access USA Conference, specifically for Patient Assistance & Access Programs. Here, she took part in the highly popular panel, “The Medicare Patient Experience: Affordability, Access, and the State of Healthcare Today,” which focused on financial burdens that patients with chronic illnesses face and why the work to improve access is far from finished. 

Gainesville, Fla. (June 1, 2025) – The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a groundbreaking grant program in partnership with Gilead Sciences aimed at advancing the field of oncology navigation and enhancing patient outcomes within the healthcare setting. This initiative is designed to support the creation, enhancement, and expansion of innovative tools that optimize efficiency and elevate the critical role of oncology navigators.

Gainesville, Fla. (May 22, 2025) – The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to announce that long-time member, and seasoned healthcare executive Rani Khetarpal, MBA, has been announced as President of its Board of Trustees for a term that will run through 2027.